IPIan Pyrah
Ian Pyrah
*This is an algorithmically generated author record based on publicly available information.
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Ian Pyrah has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Kathrin Locher
Department of Comparative Biology and Safety Sciences, Amgen Inc., One Amgen Center Drive, Thousand Oaks, CA 91320, USA
2 shared publications - Michael Stuart Ominsky
Discovery Research, Amgen, Thousand Oaks, California
2 shared publications - Rogely Waite Boyce
Department of Comparative Biology and Safety Sciences, Amgen Inc., One Amgen Center Drive, Thousand Oaks, CA 91320, USA
2 shared publications - Danielle L. Brown
Charles River Laboratories, Durham, NC, USA
1 shared publication - Efrain Pacheco
Department of Comparative Biology and Safety Sciences, Amgen Inc., One Amgen Center Drive, Thousand Oaks, CA 91320, USA
1 shared publication - Melanie Felx
Charles River Laboratories, 22022 Transcanadienne, Senneville, QC H9X 3R3, Canada
1 shared publication
Latest Publications
- Open Access
- 1 June 2018
- Published by Elsevier in Bone Reports
- Vol. 8, 95-103
Differential time-dependent transcriptional changes in the osteoblast lineage in cortical bone associated with sclerostin antibody treatment in ovariectomized rats
- 1 June 2018
- Published by Elsevier in Bone Reports
- Vol. 8, 95-103
Open AccessDifferential time-dependent transcriptional changes in the osteoblast lineage in cortical bone associated with sclerostin antibody treatment in ovariectomized rats
- Open Access
- 1 June 2018
- Published by Elsevier in Bone Reports
- Vol. 8, 90-94
Decreased osteoprogenitor proliferation precedes attenuation of cancellous bone formation in ovariectomized rats treated with sclerostin antibody
- 1 June 2018
- Published by Elsevier in Bone Reports
- Vol. 8, 90-94
Open AccessDecreased osteoprogenitor proliferation precedes attenuation of cancellous bone formation in ovariectomized rats treated with sclerostin antibody